RESEARCH TRIANGLE PARK, N.C., Dec. 13, 2022 -- Pappas Capital, a global venture capital and commercial development firm, announced today the appointment of Richard Staub as Venture Partner. His appointment...
Biovitrum and Syntonix set to begin Phase 1/2a clinical trial for the treatment of Hemophilia B
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.